Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 4—April 2009

Dispatch

Co-infection with Pansensitive and Multidrug-Resistant Strains of Mycobacterium tuberculosis

Michael P. MendezComments to Author , Mary E. Landon, Mary K. McCloud, Peter Davidson, and Paul J. Christensen
Author affiliations: Department of Veterans Affairs Medical Center, Ann Arbor, Michigan, USA (M.P. Mendez, P.J. Christensen); Washtenzw County Public Health Department, Ypsilanti, Michigan, USA (M.E. Landon M.K. McCloud); Department of Community Health, Lansing, Michigan, USA (P. Davidson)

Main Article

Table

Selected analyses of sputum from patient with tuberculosis over the course of treatment during 2007*

Date Isolate Smear Culture Resistance† Spoligotype MIRU
Jan 4 1 Positive Positive None 000000004020771 224323-53313
Jul 12 2 Negative Positive I, R, P, E 777756777760771 224325153226
Sep 8 2 Positive Positive I, R, P, E 777756777760771 224325153226

*Molecular characterization was performed on Sep 8 to confirm the presence of the second isolate and reassess for presence of the original isolate. MIRU, mycobacterial interspersed repeat units.
†I, isoniazid; R, rifampin; P, pyrazinamide; E, ethambutol.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO